Biodesix (BDSX) Equity Ratio (2019 - 2026)

Biodesix has reported Equity Ratio for 8 years, with the latest figure at 0.1 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio fell 24.76% year-over-year to 0.1; the trailing twelve-month figure through Mar 2026 stood at 0.1 (down 24.76% YoY), and the FY2025 full-year result was 0.03, down 113.13% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.1, up from 0.03 in the prior quarter.
• The five-year high for Equity Ratio was 0.31 in Q2 2024, with the low at 0.09 in Q2 2023.
• Historically, Equity Ratio has averaged 0.08 across 5 years, with a median of 0.06 in 2023.
• The largest YoY upside for Equity Ratio was 1727.28% in 2024 against a maximum downside of 212.04% in 2024.
• Biodesix's Equity Ratio stood at 0.22 in 2022, then plunged by 79.16% to 0.05 in 2023, then surged by 364.49% to 0.21 in 2024, then tumbled by 113.13% to 0.03 in 2025, then surged by 442.43% to 0.1 in 2026.
• The last three Equity Ratio figures came in at 0.1 (Q1 2026), 0.03 (Q4 2025), and 0.02 (Q3 2025), per Business Quant data.